Dana Aftab - Feb 15, 2025 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
CSO/EVP Disc & Trans Research
Signature
/s/ Nina Ayer, Attorney in Fact
Stock symbol
EXEL
Transactions as of
Feb 15, 2025
Transactions value $
-$1,006,180
Form type
4
Date filed
2/19/2025, 08:31 PM
Previous filing
Jan 17, 2025
Next filing
Feb 26, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Tax liability -$562K -16.1K -2.83% $35.00 552K Feb 15, 2025 Direct F1, F2
transaction EXEL Common Stock Tax liability -$444K -12.7K -2.3% $35.00 539K Feb 15, 2025 Direct F2, F3
holding EXEL Common Stock 5.84K Feb 15, 2025 By 401(k) F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2021, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 11, 2024.
F2 Includes 259,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F3 Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of RSUs awarded January 5, 2023.
F4 Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 14, 2025.